Delisted
Stopped trading. Fund positions aren't valued until we confirm what happened.
ALPINE IMMUNE SCIENCES INC
ALPN·02083G100·US·Common Stock
ALPN (ALPINE IMMUNE SCIENCES INC) is held by 0 institutional investors as of Q2 2024.
0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold ALPN.
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $1,784 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $27,708 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $122.1M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $17.8M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.8M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $6.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $4.7M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $529,471 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $8.2M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $26.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.2M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $25,805 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $9.3M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $786,299 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $780,948 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $752,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $3.1M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $3.2M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $950,171 | 0.0% | — | 0 |
Showing 1-20 of 97
1 / 5
ALPNALPINE IMMUNE SCIENCES INCContinue exploring
Similar stocks
FISVFiserv Inc334 holders · $21.5B
SPYSPDR S&P 500 ETF Trust294 holders · $348.2B
IVViShares Core S&P 500 ETF262 holders · $566.9B
QQQInvesco QQQ Trust Series 1246 holders · $125.8B
VOOVANGUARD S&P500 INDEX ETF245 holders · $264.7B
IWMiShares Russell 2000 ETF242 holders · $68.1B
GLDSPDR GOLD TRUST GOLD SHS237 holders · $34.1B
XLFFinancial Select Sector SPDR Fund224 holders · $31.5B
XLEEnergy Select Sector SPDR Fund223 holders · $17.3B
EFAiShares MSCI EAFE ETF221 holders · $47.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer